期刊文献+

百日咳毒素减轻实验性自身免疫性脑脊髓炎小鼠模型炎症反应的机制研究 被引量:4

Mechanism of action of pertussis toxin in alleviating inflammatory response in the mouse model of experimental autoimmune encephalomyelitis
下载PDF
导出
摘要 目的探讨百日咳毒素(PTx)对实验性自身免疫性脑脊髓炎(EAE)小鼠模型的作用及机制。方法将C57BL/6小鼠随机分为正常对照组、EAE组和PTx治疗组,每组12只。EAE组和PTx治疗组用MOG 35-55诱导EAE模型。PTx组于建模后第7天给予腹腔注射1000 ng的PTx。随后观察两组临床症状,组织学染色评价炎症反应和脱髓鞘改变,并观察VEGF和血管新生现象,并用Western blot检测脊髓VEGF和Collagen IV的整体水平。在体外,用PTx刺激原代培养的神经元,评价PTx对在体外对神经元VEGF表达的影响。结果 PTx能减轻EAE模型的炎症反应和脱髓鞘改变,在大脑PTx将炎症评分从(3.4±0.55)分降至(1.2+0.45)分,P<0.01;脱髓鞘评分从(3.6+0.55)分降至(1.4+0.55)分,P<0.01。在脊髓PTx将炎症评分从(3.6+0.55)分降至(1.0+0.71)分,P<0.01;脱髓鞘评分从(4.2+0.84)分降至(1.4+0.55)分,P<0.01。Western blot检测显示,与正常对照组比较,EAE组VEGF下降49.0%(P<0.01),Collagen IV下降36.0%(P<0.01);PTx治疗后,与EAE组比较,VEGF上升59.5%(P<0.01),Collagen IV上升45.0%(P<0.01)。体外实验显示,PTx治疗24 h后VEGF在神经元上的表达增加,与正常对照相比,100 ng/ml组上调34.6%(P<0.01),400 ng/ml组上调76.9%(P<0.01)。结论 PTx可上调神经元内源VEGF的表达和血管新生现象,继而在EAE模型中起保护作用。 Objective To investigate the role and mechanism of action of pertussis toxin( PTx) in the mouse model of experimental autoimmune encephalomyelitis( EAE). Methods C57 BL /6 mice were randomly divided into normal control group,EAE group,and PTx treatment group,with 12 mice in each group. In the EAE group and PTx treatment group,EAE model was established using MOG 35- 55,and the mice in the PTx treatment group were given 1000 ng intraperitoneally injected PTx at 7 days after modeling. The clinical symptoms were observed in these two groups. Histological staining was used to evaluate inflammatory response and changes in demyelination and observe vascular endothelial growth factor( VEGF) and angiogenesis. Western blot was used to measure the levels of VEGF and collagen IV. PTx was used to stimulate primary cultured neurons in vitro to assess the in vitro effect of PTx on VEGF expression in neurons. Results PTx alleviated the inflammatory response and demyelination in EAE model,and in the brain,PTx treatment reduced the inflammation score from 3. 4 ± 0. 55 to1. 2 ± 0. 45( P 0. 01) and the demyelination score from 3. 6 ± 0. 55 to 1. 4 ± 0. 55( P 0. 01). In the spinal cord,PTx treatment reduced the inflammation score from 3. 6 ± 0. 55 to 1. 0 ± 0. 71( P 0. 01) and the demyelination score from 4. 2 ± 0. 84 to 1. 4 ± 0. 55( P 0. 01). The results of Western blot showed that compared with the normal control group,the EAE group showed a 49. 0% reduction in VEGF( P 0. 01)and a 36. 0% reduction in Collagen IV( P 0. 01); compared with the EAE group,the PTx treatment group showed a 59. 5% increase in VEGF( P 0. 01) and a 45. 0% increase in collagen IV( P 0. 01). The in vitro experiment showed that at 24 hours after PTx treatment,the expression of VEGF in neurons was upregulated; compared with the normal control group,the 100 ng / ml group showed a 34. 6% increase in the expression of VEGF,and the 400 ng / ml group showed a 76. 9% increase. Conclusions PTx can upregulate endogenous VEGF in neurons and angiogenesis,and thus exerts a protective effect in EAE model.
出处 《国际神经病学神经外科学杂志》 北大核心 2016年第2期112-118,共7页 Journal of International Neurology and Neurosurgery
基金 国家自然科学基金项目(81360204) 云南省卫生科技计划项目(2014NS178)
关键词 百日咳毒素 多发性硬化 血管内皮生长因子 神经元 血管新生 小鼠 pertussis toxin multiple sclerosis vascular endothelial growth factor neuron angiogenesis mouse
  • 相关文献

参考文献30

  • 1Yin JX, Tu JL, Lin HJ, et al. Centrally administered per- tussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model. PLoS One, 2010, 5: e12400.
  • 2Kirk SL, Karlik SJ. VEGF and vascular changes in chronic neuroinflammation. J Autoimmun, 2 0 0 3 , 21 : 3 5 3 - 3 6 3.
  • 3Roscoe WA, Welsh ME, Carter DE, et al. VEGF and an- giogenesis in acute and chronic MOG (( 35-55 )) peptide induced EAE. J Neuroimmunol, 2009, 209: 6-15.
  • 4Proescholdt MA, Jacobson S, Tresser N, et al. Vascular en- dothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol, 2002, 61: 914-925.
  • 5Lu C, Peleeh S, Zhang H, et al. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J Neu-rosci Res, 2008, 86: 2624-2640.
  • 6Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue--beyond blood vessels. Exp Neurol, 2004, 187 : 246-253.
  • 7Storkebaum E, Lambrechts D, Carmeliet P. VEGF : once re- garded as a specific angiogenic factor, now implicated in neu- roprotection. Bioessays, 2004, 26 : 943-954.
  • 8Tonra JR, Reiseter BS, Kolbeck R, et al. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neu- rol, 2001, 430: 131-144.
  • 9Okuda Y, Sakoda S, Fujimura H, et al. IL-6 plays a eru- c, ial role in the induction phase of myelin oligodendroeyte glu- eoprotein 35 -55 induced experimental autoimnmne encephalo- myelitis. J Neuroimmunol, 1999, 101 : 188-196.
  • 10Kuerten S, Kostova-Bales DA, Frenzel LP, et al. MP4-and MOG: 35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J Neuroimmunol, 2007, 189: 31-40.

二级参考文献27

  • 1Sadovnick AD, Eisen K, Ebers GC, et al. Cause of death in patients attending multiple sclerosis clinics. Neurology, 1991, 41(8) : 1193-1196.
  • 2Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry, 1987, 50(5) : 523-531.
  • 3Hirst C, Swingler R, Compston DA, et al. Survival and cause of death in multiple sclerosis: a prospective population- based study. J Neurol Neurosurg Psychiatry, 2008, 79 (9) : 1016-1021.
  • 4Allen NB, Liehtman JH, Cohen HW, et al. Vascular dis- ease among hospitalized multiple sclerosis patients. Neuroepi- demiology, 2008, 30(4) : 234-238.
  • 5Christiansen CF, Christensen S, Farkas DK, et al. Risk of" arterial cardiovascular diseases in patients with multiple sclero- sis: a population-based cohort study. Neuroepidemiology, 2010, 35(4) : 267-274.
  • 6Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unseleeted cohort of the elderly: molecular pa- thology suggests origin from chronic hypoperfusion injury. Stroke, 2006, 37(6) : 1391-1398.
  • 7Wosik K, Antel J, Kuhlmann T, et al. Oligodendrocyte in-jury in multiple sclerosis: a role for p53. J Neurochem, 2003, 85(3) : 635-644.
  • 8Sternberg Z, Drake A, Sternberg DS, et al. Lp-PLA2 : in- flammatory biomarker of vascular risk in multiple sclerosis. J C[in Immunol, 2012, 32(3 ) : 497-504.
  • 9Sternberg Z, Hennies C, Sternberg D, et al. Plasma pentosi- dine: a potential biomarker in the management of multiple sclerosis. Mult Scler, 2011, 17 (2) : 157-163.
  • 10Newcombe J, Li H, Cuzner ML. Low density lipoprotein up- take by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol, 1994, 20 (2) : 152-162.

共引文献3

同被引文献29

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部